COVID-19-associated endotheliopathy has also been linked to increases in von Willebrand factor (vWF) release, platelet activation, and hypercoagulability, which collectively drive venous, arterial, and microvascular thrombosis [45]. This evidence concerns the gene VWF and COVID-19.